INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

21,588 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$18K
558 sh
Mar 27, 2026Mar 31, 2026
Page 347 of 540
← PrevNext →
traded Mar 27, 2026
+4d
SEC Form 4

Evidence

26
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Open-market sale · 10b5-1 plan
SELL$268K
50.0K sh
Mar 26, 2026Mar 31, 2026
traded Mar 26, 2026
+5dSEC Form 4

Evidence

26
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$15K
488 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

25
BS
Bimes Randy S.Director
QNBCQNB CORP.
Open-market purchase
BUY$10,000
263 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

25
TM
Tirman MatthewPresident
SATLSatellogic Inc.
Open-market sale
SELL$49K
9,499 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

24
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$332K
68.0K sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

21
LW
Lozinski Jeffrey William10% Owner
KSEZKinetic Seas Inc.
Open-market sale
SELL$3,000
100.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

20
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Open-market sale · 10b5-1 plan
SELL$265K
50.0K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

19
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$241K
19.1K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

19
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$256K
19.1K sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

19
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$220K
16.3K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

18
LJ
Locascio Dirk J.EVP, Chief Financial Officer
USFDUS Foods Holding Corp.
Open-market sale · 10b5-1 plan
SELL$1.82M
20.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

17
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$83K
17.5K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

17
DM
D'Annunzio MarcGeneral Counsel and Secretary
BKKTBakkt, Inc.
Open-market sale · 10b5-1 plan
SELL$55K
6,422 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

17
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$79K
15.5K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

16
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$34K
2,738 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

15
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$2.96M
19.6K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

12
CJ
Cumello JosephSVP, General Mgr. Blue Planet
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$700K
1,773 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

8
HM
Hoffmann MartinCEO
ONONOn Holding AG
Open-market sale · 10b5-1 plan
SELL$134K
4,150 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

6
DM
D'Annunzio MarcGeneral Counsel and Secretary
BKKTBakkt, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
5,342 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

6
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$175K
1,200 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

57
SB
Schimmelpennink Evert B.Director, President, CEO and Secretary
LENZLENZ Therapeutics, Inc.
Open-market purchase
BUY$251K
28.1K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

52
AA
Arima AnastasiosChief Executive Officer
IPXIPERIONX Ltd
Open-market purchase
BUY$300K
12.8K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

51
GP
George Jeffrey P.Director
LENZLENZ Therapeutics, Inc.
Open-market purchase
BUY$50K
5,592 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

50
CR
Chevallard Daniel R.Chief Financial Officer
LENZLENZ Therapeutics, Inc.
Open-market purchase
BUY$64K
7,500 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

50
JM
Jansen John MDirector
OKLOOklo Inc.
Open-market sale
SELL$541K
10.5K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

49
SW
Sheehan William W IIEVP, CHIEF FINANCIAL OFFICER
ROSTROSS STORES, INC.
Open-market sale
SELL$1.06M
4,883 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

49
GD
Golub DavidDirector, CEO and Chairman, 10% Owner
NONENONEGolub Capital Private Income Fund I
Open-market purchase
BUY$12.50M
511.2K sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

44
AD
Aguirre DeAnneDirector
HTGCHercules Capital, Inc.
Open-market purchase
BUY$105K
7,317 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

43
GP
Griscom PaulSVP and Controller
MMacy's, Inc.
Open-market sale
SELL$52K
2,919 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

43
AA
Arima AnastasiosChief Executive Officer
IPXIPERIONX Ltd
Open-market purchase
BUY$1.49M
467.0K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

43
BO
Bron OlivierCEO, Bloomingdale's
MMacy's, Inc.
Open-market sale
SELL$84K
4,712 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

40
HT
Hannigan ToddDirector
IPXIPERIONX Ltd
Open-market purchase
BUY$721K
225.2K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

36
BN
Brown Carol NDirector
SLGSL GREEN REALTY CORP
Open-market sale
SELL$182K
5,004 sh
Mar 30, 2026Mar 30, 2026
traded Mar 30, 2026
+0dSEC Form 4

Evidence

36
TO
Tepper OrenCRO
NYAXNayax Ltd.
Open-market sale
SELL$3,143
57 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

36
MS
Manor SagitCFO
NYAXNayax Ltd.
Open-market sale
SELL$4,356
79 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

36
SM
Sever MichalCMO
NYAXNayax Ltd.
Open-market sale
SELL$1,909
35 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

36
GS
Greenberg Aaron SamuelCSO
NYAXNayax Ltd.
Open-market sale
SELL$2,945
54 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

36
FL
Furman Carly LisanneCEO NAYX North America
NYAXNayax Ltd.
Open-market sale
SELL$6,065
110 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

34
BJ
Bingham JonathanGlobal Financial Controller
HSBCHSBC HOLDINGS PLC
Open-market purchase
BUY$205
13 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence